AIIMS study finds ivermectin prophylaxis reduces covid - 19 infection by 73 percent.

Medogle News Network   |  


Photo Credit: For representational purpose only

In a significant finding, two-dose Ivermectin prophylaxis has led to 73 per cent reduction in COVID-19 infection among healthcare workers (HCWs), who are more likely to contract the virus given the high exposure involved with their job as frontline workers. 

The findings of the study conducted by AIIMS-Bhubaneswar between September 20 and October 19 is set to provide new direction to the ongoing research on the behaviour of SARS-CoV2 and prevention and treatment of COVID-19.

Between 20 September and 19 October, 12 physicians of AIIMS-Bhubaneshwar conducted the study on healthcare workers (HCWs) at risk of virus exposure.

Ivermectin is one among several potential drugs currently in trials for its therapeutic and preventive role in Covid-19 infection.

Performed on two sets of HCWs, the study evaluated the association between the drug and development of Covid-19 infection, The New Indian Express reported.

In the two-cohort study, one set of HCWs received two-dose ivermectin prophylaxis at a dose of 300 μg / kg with a gap of 72 hours while workers in the other group received other prophylaxis.

With around 4,600 employees, over 625 employees of the institute tested positive for Covid-19.

The month-long study took place using 372 participants, including doctors, nurses, paramedics and sanitisation workers.

Based on WHO risk assessment guidelines, the contact tracing team of the institute made the list depending on subjects’ exposure to the disease.

AIIMS Director and corresponding author of the study Gitanjali Batmanabane said:

“Earlier, at least 20 to 25 HCWs were getting infected with the virus daily. After the workers started taking ivermectin, the number of infection has come down to one or two per day.”

Earlier , UP Government too, included ivermectin for prophylactic use among frontline workers and those who came in contact with covid positive patients. 

Leave a Comment

0 Comment(s)